REQUEST A DEMO
Total
USD $0.00
Search more companies

Smc Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Periodical Publishers | Lessors of Real Estate | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | General Medical and Surgical Hospitals | Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
Full name: Smc Pharma Sp. z o.o. Profile Updated: May 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Smc Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Krakow. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 28, 2012. 1 (2015) employees currently work for Smc Pharma Sp. z o.o.. Over the same period, its total assets decreased by 25.31%.

Headquarters
Ul. Al. Mickiewicza 21
Krakow; Malopolskie; Postal Code: 31-120

Contact Details: Purchase the Smc Pharma Sp. z o.o. report to view the information.

Website: http://smcpharma.pl/

Basic Information
Total Employees:
Purchase the Smc Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Smc Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Smc Pharma Sp. z o.o. report to view the information.
Incorporation Date:
May 28, 2012
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Smc Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
33.33%
Net Profit (Loss) for the Period
33.33%
Total assets
-25.31%
Total equity
-0.54%
Return on Equity (ROE)
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?